Figure 1From: A novel MHC- dextramer assay to identify melanoma antigen-specific CD8+ T cells from solid tumor disaggregates and matched peripheral bloodRight: MART-1 specific Dextramer detects CD8+ cell in ELAGIGILTV peptides cultured PBMC isolated from HLA A*0201 subtype. Q2 region captured CD8+ T/MART-1 specific T Cell, Left: Disaggregates of Melanoma tumor Dextramer straining.Back to article page